Setbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk

Dow Jones

2022/09/06

1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak)

$(END)$ Dow Jones Newswires

September 06, 2022 10:55 ET (14:55 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2265918700"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2265918700\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2265918700?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-06 22:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2265918700","market":"us","top_or_hot":-1,"title":"Setbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak) \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  September 06, 2022 10:55 ET (14:55 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Setbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSetbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-09-06 22:55</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak) \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  September 06, 2022 10:55 ET (14:55 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2265918700","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2265918700","pubTimestamp":1662476100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it ex","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ALNA":"Allena Pharmaceuticals Inc."},"translate_title":"肾脏和痛风药物的挫折导致Allena破产--市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"END":1,"ALNA":0.9},"content_text":"1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak) \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  September 06, 2022 10:55 ET (14:55 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}